Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development.


Autoria(s): Audi, L; Fernández-Cancio, M; Carrascosa, A; Andaluz, P; Torán, N; Piró, C; Vilaró, E; Vicens-Calvet, E; Gussinyé, M; Albisu, M A; Yeste, D; Clemente, M; Hernández de la Calle, I; Campo, M Del; Vendrell, T; Blanco, A; Martínez-Mora, J; Granada, M L; Salinas, I; Forn, J; Calaf, J; Angerri, O; Martínez-Sopena, M J; Valle, J Del; García, E; Gracia-Bouthelier, R; Lapunzina, P; Mayayo, E; Labarta, J I; Lledó, G; Sánchez Del Pozo, J; Arroyo, J; Pérez-Aytes, A; Beneyto, M; Segura, A; Borrás, V; Gabau, E; Caimarí, M; Rodríguez, A; Martínez-Aedo, M J; Carrera, M; Castaño, L; Andrade, M; Bermúdez de la Vega, J A
Data(s)

10/10/2013

10/10/2013

01/04/2010

Resumo

BACKGROUND Androgen receptor (AR) gene mutations are the most frequent cause of 46,XY disorders of sex development (DSD) and are associated with a variety of phenotypes, ranging from phenotypic women [complete androgen insensitivity syndrome (CAIS)] to milder degrees of undervirilization (partial form or PAIS) or men with only infertility (mild form or MAIS). OBJECTIVE The aim of the study was to characterize the contribution of the AR gene to the molecular cause of 46,XY DSD in a series of Spanish patients. SETTING We studied a series of 133 index patients with 46,XY DSD in whom gonads were differentiated as testes, with phenotypes including varying degrees of undervirilization, and in whom the AR gene was the first candidate for a molecular analysis. METHODS The AR gene was sequenced (exons 1 to 8 with intronic flanking regions) in all patients and in family members of 61% of AR-mutated gene patients. RESULTS AR gene mutations were found in 59 individuals (44.4% of index patients), of whom 46 (78%) were CAIS and 13 (22%) PAIS. Fifty-seven different mutations were found: 21.0% located in exon 1, 15.8% in exons 2 and 3, 57.9% in exons 4-8, and 5.3% intronic. Twenty-three mutations (40.4%) had been previously described and 34 (59.6%) were novel. CONCLUSIONS AR gene mutation is the most frequent cause of 46,XY DSD, with a clearly higher frequency in the complete phenotype. Mutations spread along the whole coding sequence, including exon 1. This series shows that 60% of mutations detected during the period 2002-2009 were novel.

Journal Article; Research Support, Non-U.S. Gov't;

This work was supported by grants from Instituto de Salud Carlos III, Madrid, Spain [PI06/0903 and CIBERER (Center for Biomedical Research on Rare Diseases)] and from AGAUR (University and Research Management and Evaluation Agency), Barcelona, Spain (SGR02 00042 and SGR05 00908).

Identificador

Audi L, Fernández-Cancio M, Carrascosa A, Andaluz P, Torán N, Piró C, et al. Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development. J. Clin. Endocrinol. Metab. 2010 ; 95(4):1876-88

1945-7197 (Online)

0021-972X (Print)

http://hdl.handle.net/10668/1323

20150575

10.1210/jc.2009-2146

Idioma(s)

en

Publicador

Endocrine Society

Relação

The Journal of clinical endocrinology and metabolism

http://jcem.endojournals.org/content/95/4/1876.abstract

Direitos

Acceso abierto

Palavras-Chave #3-oxo-5-alfa-esteroide 4-deshidrogenasa #Exonas #Disgenesia gonadal 46XY #Heterocigoto #Intrones #Mutación #Receptores de andrógenos #Reacción en cadena de la polimerasa por transcriptasa inversa #Medical Subject Headings::Named Groups::Persons::Age Groups::Adolescent #Medical Subject Headings::Named Groups::Persons::Age Groups::Child #Medical Subject Headings::Named Groups::Persons::Age Groups::Child::Child, Preschool #Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Gene Components::Exons #Medical Subject Headings::Check Tags::Female #Medical Subject Headings::Anatomy::Cells::Connective Tissue Cells::Fibroblasts #Medical Subject Headings::Diseases::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Congenital Abnormalities::Urogenital Abnormalities::Disorders of Sex Development::46, XY Disorders of Sex Development::Gonadal Dysgenesis, 46,XY #Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genotype::Heterozygote #Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans #Medical Subject Headings::Named Groups::Persons::Age Groups::Infant #Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Gene Components::Introns #Medical Subject Headings::Check Tags::Male #Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation #Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Phenotype #Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Transcription Factors::Receptors, Cytoplasmic and Nuclear::Receptors, Steroid::Receptors, Androgen #Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Nucleic Acid Amplification Techniques::Polymerase Chain Reaction::Reverse Transcriptase Polymerase Chain Reaction #Medical Subject Headings::Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Sexual Behavior #Medical Subject Headings::Anatomy::Urogenital System::Genitalia::Gonads::Testis #Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Oxidoreductases::Oxidoreductases Acting on CH-CH Group Donors::3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/published

Artículo